secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clene Inc. (CLNN)
CIK:        0001822791
Form:       8-K
Filed at:   2024-09-30T23:59:59+00:00
Accession:  0001437749-24-030263
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clene announces $7.3M registered direct offering and concurrent private placements
--------------------------------------------------------------------------------

- Gross proceeds ~$7.3M; shares/pre-funded warrants at $4.713 combined with warrants ($4.82 strike, 5-year term).
- Warrants exercisable immediately; lock-up until later of 45 days or FDA meeting outcome announcement.
- Directors/officers bought 122,819 shares at $4.875/warrant package; existing investors also participated.
- Proceeds to fund clinical development of lead candidate CNM-Au8 (ALS/MS) and general corporate purposes.
- Canaccord Genuity acted as sole placement agent; closing expected on or about October 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822791/000143774924030263/0001437749-24-030263-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822791/000143774924030263/clnn20240928_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-030263

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer